Literature DB >> 8141567

In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents.

N Khardori1, H Nguyen, B Rosenbaum, K Rolston, G P Bodey.   

Abstract

The in vitro antimicrobial susceptibilities of 42 isolates of rapidly growing mycobacteria (Mycobacterium fortuitum, M. chelonae, and Mycobacterium species [other than M. fortuitum and M. chelonae]) to nine quinolones, including newer agents, two new aminoglycosides, and an aminocyclitol (trospectomycin) were determined by a broth microdilution method. The new quinolones, PD 117596, PD 127391, and PD 117558, showed excellent in vitro activities against M. fortuitum (MICs for 90% of isolates [MIC90s], 0.06, 0.06, and 0.12 microgram/ml, respectively). The MIC90 of ciprofloxacin for M. fortuitum was 0.5 microgram/ml. Only 14 to 28% of isolates of M. chelonae were susceptible to various quinolones. Most isolates of all three species were susceptible to the new aminoglycosides SCH 21420 and SCH 22591. The MIC90s of trospectomycin were 8 micrograms/ml for M. chelonae, 32 micrograms/ml for Mycobacterium species, and > 64 micrograms/ml for M. fortuitum.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8141567      PMCID: PMC284409          DOI: 10.1128/AAC.38.1.134

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  36 in total

1.  Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents.

Authors:  W E Sanders; E C Hartwig; N J Schneider; R Cacciatore; H Valdez
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

2.  In vitro evaluation of S-25930 and S-25932, two new quinolones, against aerobic gram-negative isolates from cancer patients.

Authors:  K V Rolston; D H Ho; B LeBlanc; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

3.  In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus.

Authors:  S M Smith
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

4.  Disseminated mycobacteriosis due to Mycobacterium abcessus in two recipients of renal homografts.

Authors:  J R Graybill; J Silva; D W Fraser; R Lordon; E Rogers
Journal:  Am Rev Respir Dis       Date:  1974-01

5.  Mycobacterium chelonei septicemia in a premature infant.

Authors:  D P Speert; D Munson; C Mitchell; D E Johnson; T R Thompson; P Ferrieri; L W Wannamaker
Journal:  J Pediatr       Date:  1980-04       Impact factor: 4.406

6.  Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci.

Authors:  D Shonekan; D Mildvan; S Handwerger
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

7.  Disseminated Mycobacterium chelonei infection: response to sulfonamides.

Authors:  A D Tice; R J Solomon
Journal:  Am Rev Respir Dis       Date:  1979-07

8.  In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin.

Authors:  J R Dalovisio; G A Pankey
Journal:  J Infect Dis       Date:  1978-03       Impact factor: 5.226

9.  In-vitro activity of two new quinolone antimicrobial agents, S-25930 and S-25932 compared with that of other agents.

Authors:  H C Neu; N X Chin
Journal:  J Antimicrob Chemother       Date:  1987-02       Impact factor: 5.790

10.  In vitro studies of S-25930 and S-25932, two new 4-quinolones.

Authors:  L J Piddock; J M Andrews; J M Diver; R Wise
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

View more
  5 in total

1.  Mycobacterium fortuitum bacteremia in an immunocompromised patient with a long-term venous catheter.

Authors:  A Moreno; M Llanos; A González; N Batista
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-05       Impact factor: 3.267

2.  New drug susceptibility test for Mycobacterium tuberculosis using the hybridization protection assay.

Authors:  J Miyamoto; H Koga; S Kohno; T Tashiro; K Hara
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

3.  Lesser known mycobacteria.

Authors:  B Watt
Journal:  J Clin Pathol       Date:  1995-08       Impact factor: 3.411

4.  In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials.

Authors:  R Fernández-Roblas; J Esteban; F Cabria; J C López; M S Jiménez; F Soriano
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

Review 5.  Activity of quinolones against mycobacteria.

Authors:  M R Jacobs
Journal:  Drugs       Date:  1995       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.